Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs

• Athanasia Stathopoulou,

  Affiliation Department of Physiology, Medical School, University of Patras, Patras, Greece

  ⨯
• Vassilis Roukos,

  Current address: Department of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Department of General Biology, Medical School, University of Patras, Patras, Greece

  ⨯
• Chariklia Petropoulou,

  Affiliation Department of Physiology, Medical School, University of Patras, Patras, Greece

  ⨯
• Panagiotis Kotsantis,

  Affiliation Department of General Biology, Medical School, University of Patras, Patras, Greece

  ⨯
• Nickolas Karantzelis,

  Affiliation Department of Physiology, Medical School, University of Patras, Patras, Greece

  ⨯
• Hideo Nishitani,

  Affiliation Department of Biological Signaling, Graduate School of Life Science, University of Hyogo, Hyogo, Japan

  ⨯
• Zoi Lygerou,

  Affiliation Department of General Biology, Medical School, University of Patras, Patras, Greece

  ⨯
• Stavros Taraviras

  * E-mail: taraviras@med.upatras.gr

  Affiliation Department of Physiology, Medical School, University of Patras, Patras, Greece

  ⨯